Organisations come together with the aim of using technology to help end preventable deaths and improve outcomes for sepsis patients
Global medical technology company, Hillrom, and The UK Sepsis Trust today announced an exclusive, year-long partnership to raise greater awareness of sepsis.
Throughout 2020 Hillrom will be working with the organisation to provide awareness and training to hospitals on how they can use existing technology to help identify deteriorating patients more quickly.
Five people die from sepsis every hour in the UK, and a quarter of all survivors suffer permanent, life-changing after-effects.
Yet earlier detection and medical intervention could help prevent such tragedies.
In fact, according to the World Health Organization, the majority of deaths caused by sepsis could be preventable by, among other factors, early detection and management.
Together, we will help to raise awareness of sepsis in both primary and secondary care settings and aim to deliver real change in terms of facilitating an early diagnosis
And technology plays a key role in the detection of patient deterioration, and by using a fully-connected vital signs patient monitor and an approved Track & Trigger System, such as NEWS2, clinicians can help deliver an Early Warning Score that aids in rapid diagnosis and treatment.
“As a charity our goal is to end preventable deaths from sepsis and improve outcomes for sepsis survivors,” said National Health Trust consultant, Dr Ron Daniels, founder of The UK Sepsis Trust.
“We believe that earlier diagnosis and treatment across the UK could save thousands of lives and are delighted to announce this exciting partnership with Hillrom.
“Together, we will help to raise awareness of sepsis in both primary and secondary care settings and aim to deliver real change in terms of facilitating an early diagnosis.”
Hillrom President and chief executive, John Groetelaars, added: “With staffing pressures in the NHS, allowing clinicians to measure a complete set of observations within a single monitoring device could potentially save lives by more-quickly identifying deterioration in a patient in a cost-efficient manner.
“This partnership supports our vision of Advancing Connected Care, and we are looking forward to working with the trust throughout 2020 to raise awareness of sepsis and the importance of early diagnosis and treatment.”